Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GENENTECH OFFERING DISCOUNTS ON HUMAN GROWTH HORMONE IN BREAK FROM PAST PRACTICES; PULMOZYME PE AND QoL DATA ARE CENTRAL IN COVERAGE NEGOTIATIONS

Executive Summary

Genentech is reconsidering its no discount policy in individual negotiations with purchasers, particularly for its human growth hormone products. Genentech Senior Director of Government Affairs Walter Moore indicated the shift in approach in comments to the Health Industry Group Purchasing Association Pharmacy Forum in New Orleans on May 5.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026187

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel